Carlos Rogério Figueiredo has received the Young Investigator Award from the Scandinavian Society for Immunology. The award is given for high-quality immunological research and promotion of the field of immunology.

Figueiredo was announced as the awardee last year at the European Congress of Immunology in Dublin and received the award this year at the SSI 2025 Conference in Stockholm.

Carlos Rogério Figueiredo is a group leader at the Institute of Biomedicine, Faculty of Medicine, University of Turku. Figueiredo and his Medical Immuno-Oncology Group (MIORG) investigate how cancer interacts with the immune system. By analysing transcriptomic and proteomic data from patient samples collected in clinical trials, the group identifies new biomarkers that predict responses to immunotherapy and evaluates their functional impact on human anti-tumor immune responses. 

“Our goal is to deepen our understanding of why some patients develop resistance to cancer immunotherapy by analysing their own samples, and to use these insights to design new, rational therapeutic combinations,” Figueiredo says.